Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 331.2 SEK 1.85% Market Closed
Market Cap: 114B SEK
Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?
Write Note

Swedish Orphan Biovitrum AB (publ)
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Swedish Orphan Biovitrum AB (publ)
Current Portion of Long-Term Debt Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
VITR
BIOA B

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Current Portion of Long-Term Debt
kr6.1B
CAGR 3-Years
42%
CAGR 5-Years
133%
CAGR 10-Years
123%
Biogaia AB
STO:BIOG B
Current Portion of Long-Term Debt
kr8.8m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Current Portion of Long-Term Debt
kr6.4m
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Current Portion of Long-Term Debt
kr8.7m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Current Portion of Long-Term Debt
kr152m
CAGR 3-Years
113%
CAGR 5-Years
61%
CAGR 10-Years
25%
BioArctic AB
STO:BIOA B
Current Portion of Long-Term Debt
kr2.8m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
6.1B SEK

Based on the financial report for Sep 30, 2024, Swedish Orphan Biovitrum AB (publ)'s Current Portion of Long-Term Debt amounts to 6.1B SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
123%

Over the last year, the Current Portion of Long-Term Debt growth was 81%. The average annual Current Portion of Long-Term Debt growth rates for Swedish Orphan Biovitrum AB (publ) have been 42% over the past three years , 133% over the past five years , and 123% over the past ten years .

Back to Top